Doctor profile · Federal record
Dr. Samer Renno, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Omaha, NE
- NPI 1588758312
- Accepts Medicare
- 30 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6901 N 72Nd St, Suite 2244
Omaha, NE 681221709
(402) 572-3535
fax (402) 572-2688 - Mailing address
-
Po Box 641850
Omaha, NE 681647850
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- July 10, 2013
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Nebraska #22157 · Iowa #32052
- Medicaid (2)
- IA #0555300 · NE #47077065413
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1588758312. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
270,240
Distinct HCPCS
10
Medicare allowed
$4,006,103
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 64,300 | 54 | $3 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 57,000 | 44 | $1 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 32,560 | 25 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 31,600 | 27 | $54 | |
J0897 |
Injection, denosumab, 1 mg | 19,440 | 61 | $23 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 10,440 | 12 | $48 | |
J1756 |
Injection, iron sucrose, 1 mg | 8,600 | 14 | $0 | |
Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 8,460 | 15 | $29 | |
J9267 |
Injection, paclitaxel, 1 mg | 6,760 | 16 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 3,695 | 95 | $0 |
In context: peer comparison
Among 16 peers in Omaha Hematology & Oncology Physician, average services per provider: 2,091. This provider delivers 129× the peer median.Open Payments
Industry payments received
All-time total
$284
Transactions
14
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 2 | $47.23 | |
| Abbvie INC. | 2 | $43.07 | |
| Merck Sharp & Dohme LLC | 2 | $36.89 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $28.99 | |
| Daiichi Sankyo INC. | 1 | $27.70 | |
| Genentech USA, INC. | 1 | $23.12 | |
| Eisai INC. | 1 | $21.30 | |
| Lilly USA, LLC | 1 | $20.77 | |
| PharmaEssentia USA Corporation | 1 | $19.86 | |
| Aveo Pharmaceuticals, INC. | 1 | $15.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,197
Patients
296
Total drug cost
$1,311,033
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 257 | 60 | $5,871 |
| Acyclovir | Generic | 108 | 27 | $1,928 |
| Tamoxifen Citrate | Generic | 103 | 29 | $3,744 |
| Prednisone | Generic | 98 | 20 | $572 |
| Levothyroxine Sodium | Generic | 91 | 14 | $682 |
| Potassium Chloride | Generic | 74 | 26 | $1,271 |
| Dexamethasone | Generic | 68 | 28 | $725 |
| Hydroxyurea | Generic | 61 | 17 | $1,463 |
| Prochlorperazine Maleate | Generic | 61 | 43 | $692 |
| Abiraterone Acetate | Generic | 58 | 0 | $140,440 |
Hospital affiliations
Frequently asked questions
What is Dr. Samer Renno's medical specialty?
Dr. Samer Renno practices Hematology & Oncology Physician in Omaha, NE.
Where does Dr. Samer Renno practice?
Dr. Samer Renno practices at 6901 N 72Nd St, Omaha, NE 681221709. Office phone: 4025723535.
What is Dr. Samer Renno's NPI?
Dr. Samer Renno's National Provider Identifier (NPI) is 1588758312, issued by NPPES.
Does Dr. Samer Renno accept Medicare assignment?
Yes. Dr. Samer Renno accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Samer Renno commonly perform?
Top Medicare-reported procedures in 2023: Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, oxaliplatin, 0.5 mg (HCPCS J9263). Source: CMS Medicare Physician & Other Practitioners file.